SYNTHETIC RETINOIDS DISSOCIATE COACTIVATOR BINDING FROM COREPRESSOR RELEASE

REFERENCES

• Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R. M. The Nuclear Receptor Superfamily: The Second Decade. Cell 1995; 83: 835–839
   PubMed Web of Science ®Google Scholar
• Gronemeyer H., Laudet V. Protein Profile 1995; 2(11), Transcription Factors 3: Nuclear Receptors
   PubMedGoogle Scholar
• Chambon P. Retinoid Signalling Pathway: Molecular and Genetic Analyses. Semin. Cell Biol. 1994; 5: 115–125
   PubMedGoogle Scholar
• Kastner P., Mark M., Chambon P. Nonsteroid Nuclear Receptors: What are Genetic Studies Telling Us About Their Role in Real Life?. Cell 1995; 83: 859–869
   PubMed Web of Science ®Google Scholar
• Dollé P., Ruberte E., Kastner P., Petkovich M., Stoner C. M., Gudas L. J., Chambon P. Differential Expression of the Genes Encoding the Retinoic Acid Receptors α, β, and γ and CRABP in the Developing Limbs of the Mouse. Nature 1989; 342: 702–705
   PubMed Web of Science ®Google Scholar
• Aranda A., Pasqual A. Nuclear Hormone Receptors and Gene Expression. Physiol. Rev. 2001; 81: 1269–1304
   PubMed Web of Science ®Google Scholar
• Glass C. K., Rosenfeld M. G. The Coregulator Exchange in Transcriptional Functions of Nuclear Receptors. Genes Dev. 2000; 14: 121–141
   PubMed Web of Science ®Google Scholar
• Voegel J., Heine M.J. S., Zechel C., Chambon P., Gronemeyer H. TIF2, a 160 kD Transcriptional Mediator for the Ligand-Dependent Activation Function AF-2 of Nuclear Receptors. EMBO J. 1996; 15(14)2667–3675
   Web of Science ®Google Scholar
• Onate S. A., Tsai S. Y., Tsai M. -J., O'Malley B. W. Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily. Science 1995; 270: 1354–1357
   PubMed Web of Science ®Google Scholar
• Hörlein A. J., Näär A. M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Söderström M., Glass C. K., Rosenfeld M. G. Ligand-Independent Repression by the Thyroid Hormone Receptor Mediated by a NUCLEAR Receptor Corepressor. Nature 1995; 377: 397–404
   PubMed Web of Science ®Google Scholar
• Chen J. D., Evans R. M. A Transcriptional Co-Repressor That Interacts With Nuclear Hormone Receptors. Nature 1995; 377: 454–457
   PubMed Web of Science ®Google Scholar
• Cavaillès V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P. J., Parker M. G. Nuclear Factor RIP 140 Modulates Transcriptional Activation by the Estrogen Receptor. EMBO J. 1995; 14(15)3741–3751
   PubMed Web of Science ®Google Scholar
• Lee C. -H., Chinpaisal C., Wei L. -N. Cloning and Characterization of Mouse RIP 140, a Corepressor for Nuclear Orphan Receptor TR2. Mol. Cell. Biol. 1998; 18(11)6745–6755
   PubMed Web of Science ®Google Scholar
• Le Douarin B., Zechel C., Garnier J. M., Lutz Y., Tora L., Pierrat B., Heery D., Gronemeyer H., Chambon P., Losson R. The N-terminal Part of TIF1, a Putative Mediator of the Ligand-Dependent Activation Function (AF-2) of Nuclear Receptors, is Fused to B-raf in the Oncogenic Protein T18. EMBO J. 1995; 14(9)2020–2033
   PubMed Web of Science ®Google Scholar
• Remboutsika E., Lutz Y., Gansmuller A., Vonesch J.-L., Losson R., Chambon P. The Putative Nuclear Receptor TIF1α is Tightly Associated With Euchromatin. J. Cell Sci. 1999; 112: 1671–1683
   PubMed Web of Science ®Google Scholar
• Le Douarin B., Nielson A. L., Garnier J. M., Ichinose H., Jeanmougin F., Losson R., Chambon P. A Possible Involvement of TIF1α and TIF1β in the Epigenetic Control of Transcription by Nuclear Receptors. EMBO J. 1996; 15(23)6701–6715
   PubMed Web of Science ®Google Scholar
• vom Baur E., Zechel C., Heery D., Heine M.J. S., Garnier J. M., Vivat V., Le Douarin B., Gronemeyer H., Chambon P. Differential Ligand-Dependent Interactions Between the AF-2 Activating Domain of Nuclear Receptors and the Putative Transcriptional Intermediary Factors mSUG1 and TIF1. EMBO J. 1996; 15(1)110–124
   PubMed Web of Science ®Google Scholar
• Rubin D. M., Coux O., Wefes I., Hengartner C., Young R. A., Goldberg A. L., Finley D. Identification of the Gal4 Suppressor SUG1 as a SUBUNIT of the Yeast 26S Proteasome. Nature 1996; 379: 655–657
   PubMed Web of Science ®Google Scholar
• Germain P., Iyer J., Zechel C., Gronemeyer H. Co-regulator Recruitment and the Mechanism of Retinoic Acid Receptor Synergy. Nature 2002; 415: 187–192
   PubMed Web of Science ®Google Scholar
• Danielian P. S., White R., Lees J. A., Parker M. G. Identification of a Conserved Region Required for Hormone Dependent Transcriptional Activation by Steroid Hormone Receptors. EMBO J. 1992; 11: 1025–1033
   PubMed Web of Science ®Google Scholar
• Durand B., Saunders M., Gaudon C., Roy B., Losson R., Chambon P. Activation Function 2 (AF2) of Retinoic Acid Receptor and 9-cis Retinoic Acid Receptor: Presence of a Conserved Autonomous Constitutive Activating Domain and Influence of the Nature of the Response Element on AF-2 Activity. EMBO J. 1994; 13: 5370–5382
   PubMed Web of Science ®Google Scholar
• Hu X., Lazar M. A. The CoRNR Motif Controls the Recruitment of Corepressors by Nuclear Hormone Receptors. Nature 1999; 402: 93–96
   PubMed Web of Science ®Google Scholar
• Perissi V., Staszewski L. M., McInerney E. M., Kurokawa R., Krones A., Rose D. W., Lambert M. H., Milburn M. V., Glass C. K., Rosenfeld M. G. Molecular Determinants of Nuclear Receptor-Corepressor Interaction. Genes Dev. 1999; 13: 3198–3208
   PubMed Web of Science ®Google Scholar
• Nagy L., Kao H. -Y., Love J. D., Li C., Banayo E., Gooch J. T., Krishna V., Chatterjee K., Evans R. M., Schwabe J.W. R. Mechanism of CorepressorBinding and Release from Nuclear Hormone Receptors. Genes Dev. 1999; 13: 3209–3216
   PubMed Web of Science ®Google Scholar
• Hu X., Lazar M. A. Transcriptional Repression by Nuclear Receptors. Trends Endocrinol. Metab. 2000; 11: 6–10
   PubMed Web of Science ®Google Scholar
• Li J., Wang J., Wang J., Nawaz Z., Liu J. M., Qin J., Wong J. Both Corepressor Proteins SMRT and N-CoR Exist in Large Protein Complexes Containing HDAC3. EMBO J. 2000; 19: 4342–4350
   PubMed Web of Science ®Google Scholar
• Heery D., Kalkhoven E., Hoare S., Parker M. G. A Signature Motif in Transcriptional Co-Activators Mediates Binding to Nuclear Receptors. Nature 1997; 387: 733–736
   PubMed Web of Science ®Google Scholar
• Chen H., Lin R. J., Xie W., Wilpitz D., Evans R. M. Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase. Cell 1999; 98: 675–686
   PubMed Web of Science ®Google Scholar
• Renaud J. -P., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal Structure of the RARγ Ligand-Binding Domain Bound to All-Trans Retionic Acid. Nature 1995; 378: 681–689
   PubMed Web of Science ®Google Scholar
• Klaholz B. P., Renaud J. -P., Mitschler A., Zusi C., Chambon P., Gronemeyer H., Moras D. Conformational Adaptation of Agonists to the Human Nuclear Receptor RARγ. Nat. Struct. Biol. 1998; 5: 199–202
   PubMedGoogle Scholar
• Nolte R. T., Wisely G. B., Westin S., Cobb J. E., Lambert M. H., Kurokawa R., Rosenfeld M. G., Willson T. M., Glass C. K., Milburn M. V. Ligand Binding and Co-Activator Assembly of the Peroxisome-Activated Receptor-γ. Nature 1998; 395: 137–143
   PubMed Web of Science ®Google Scholar
• Shiau A. K., Barstad D., Loria P. M., Cheng L., Kushner P. J., Agard D. A., Greene G. L. The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen. Cell 1998; 95: 927–937
   PubMed Web of Science ®Google Scholar
• Renaud J. P., Moras D. Structural Studies on Nuclear Receptors. Cell. Mol. Life Sci. 2000; 57: 1748–1769
   PubMed Web of Science ®Google Scholar
• Bourguet W., Vivat V., Wurtz J. -M., Chambon P., Gronemeyer H., Moras D. Crystal Structure of a Heterodimeric Complex of RAR and RXR Ligand-Binding Domains. Mol. Cell 2000; 5: 289–298
   PubMed Web of Science ®Google Scholar
• Brzozowski A. M., Pike A. C., Dauter Z., Hubbard R. E., Bonn T., Engström O., Öhman L., Greene G. L., Gustafsson J-A., Carlquist M. Molecular Basis of Agonism and Antagonism in the Oestrogen Receptor. Nature 1997; 389: 753–758
   PubMed Web of Science ®Google Scholar
• Ruthardt A., Testa U., Nervi C., Ferrucci P. F., Grignani F., Puccetti E., Grignani F., Peschle C., Pelicci P. G. Opposite Effects of the Acute Promyelocytic Leukemia PML-Retinoic Acid Receptor α (RARα) and PLZF-RARα Fusion Proteins on Retinoic Acid Signalling. Mol. Cell. Biol. 1997; 17: 4859–4869
   PubMed Web of Science ®Google Scholar
• Grignani F., De Matteis S., Nervi C., Tomassoni L., Gelmetti V., Cioce M., Fanelli M., Ruthardt M., Ferrara F. F., Zamir I., Seiser C., Grignani F., Lazar M. A., Minucci S., Pelicci P. G. Fusion Proteins of the Retinoic Acid Receptor-α Recruit Histone Deacetylase in Promyelocytic Leukemia. Nature 1998; 391: 815–818
   PubMed Web of Science ®Google Scholar
• Chen J. -Y., Clifford J., Zusi C., Starrett J., Tortolani D., Ostrowski J., Reczek P. R., Chambon P., Gronemeyer H. Two Distinct Actions of Retinoid Ligands. Nature 1996; 382: 819–822
   PubMed Web of Science ®Google Scholar
• Ausubel F. M., Brent R., Kingston R., Moore D., Seidman J. J., Smith J., Struhl K. Current Protocols in Molecular Biology. John Wiley & Sons, New York 1993
   Google Scholar
• Tora L., White J., Brou C., Tasset D., Webster N., Scheer E., Chambon P. The Human Estorgen Receptor Has Two Independent Nonacidic Transcriptional Activation Functions. Cell 1989; 59: 477–487
   PubMed Web of Science ®Google Scholar
• Nagpal S., Friant S., Nakshatri H., Chambon P. RARs and RXRs: Evidence for the Two Autonomous Transactivation Functions (AF-1 and AF-2) and Heterodimerization In Vivo. EMBO J. 1993; 12: 2349–2360
   PubMed Web of Science ®Google Scholar
• Nagpal S., Saunders M., Kastner P., Durand B., Nakshatri H., Chambon P. Promoter-Context and Response Element-Dependent Specificity of the Transcriptional Activation Functions of Retinoic Acid Receptors. Cell 1992; 70: 1007–1019
   PubMed Web of Science ®Google Scholar
• Vivat V., Zechel C., Wurtz J. -M., Bourguet W., Kagechicka H., Umemiya H., Shudo K., Moras D., Gronemeyer H., Chambon P. A Mutation Mimicking Ligand-Induced Conformational Change Yields a Constitutive RXR That Senses Allosteric Effects in Heterodimers. EMBO J. 1997; 16: 5697–5709
   PubMed Web of Science ®Google Scholar
• Voegel J., Heine M.J. S., Tini M., Vivat V., Chambon P., Gronemeyer H. The Coactivator TIF2 Contains Three Nuclear Receptor-Binding Motifs and Mediates Transactivation Through CBP Binding-Dependent and -Independent Pathways. EMBO J. 1998; 17: 507–519
   PubMed Web of Science ®Google Scholar
• Bocquel M. T., Kumar V., Stricker C., Chambon P, Gronemeyer H. The Contribution of the N–and C-Terminal Regions of Steroid Receptors to Activation of Transcription is Both Receptor‐ and Cell-Specific. Nucl. Acids Res. 1989; 17: 2581–2595
   PubMed Web of Science ®Google Scholar
• Bourguet W., Andry V., Iltis C., Klaholz B., Potier N., van Dorsselaer A., Chambon P., Gronemeyer H., Moras D. Heterodimeric Complex of RAR and RXR Nuclear Receptor Ligand-Binding Domains: Purification, Crystallization, and Preliminary X-Ray Diffraction Analysis. Protein Expr. Purif. 2000; 19: 284–288
   PubMed Web of Science ®Google Scholar
• Keidel S., LeMotte P, Apfel C. Different Agonist–and Antagonist-Induced Conformational Changes in Retinoic Acid Receptors Analyzed by Protease Mapping. Mol. Cell. Biol. 1994; 14: 287–298
   PubMed Web of Science ®Google Scholar
• Géhin M., Vivat V., Wurtz J. -M., Losson R., Chambon P., Moras P., Gronemeyer H. Structural Basis for Engineering of Retinoic Acid Receptor Isotype-Selective Agonists and Antagonists. Chem. Biol. 1999; 6: 519–529
   PubMed Web of Science ®Google Scholar
• Otrowski J., Roalsvig T., Hammer L., Marinier A., Starrett J. E., Jr., Yu K. -L., Reczek P. Serine 232 and Methionine 272 Define the Ligand Binding Pocket in Retinoic Acid Receptor Subtypes. J. Biol. Chem. 1998; 273: 3490–3495
   PubMed Web of Science ®Google Scholar
• Chen J. -Y., Penco S., Ostrowski J., Balguer P., Pons M., Starrett J. E., Reczek P., Chambon P., Gronemeyer H. RAR-Specific Agonist/Antagonists Which Dissociate Transactivation and AP1 Transrepression Inhibit Anchorage-Independent Cell Proliferation. EMBO J 1995; 14: 1187–1197
   PubMed Web of Science ®Google Scholar
• Roy B., Taneja R., Chambon P. Synergistic Activation of Retinoic Acid (RA)-Responsive Genes and Induction of Embryonal Carcinoma Cell Differentiation by an RA Receptor α (RARα)-, RARβ, or RARγ-Selective Ligand in Combination With a Retinoid X Receptor-Specific Ligand. Mol. Cell. Biol. 1995; 15: 6481–6487
   PubMed Web of Science ®Google Scholar
• Taneja R., Roy B., Plassat J. -L., Zusi C., Ostrowski J., Reczek P., Chambon P. Cell-Type and Promoter-Context Dependent Retinoic Acid Receptor (RAR) Redundancies for RARβ1 and Hoxa-1 Activation in F9 and P19 Cells Can be Artefactually Generated by Gene Knockouts. Proc. Natl. Acad. Sci. USA 1996; 93: 6197–6202
   PubMed Web of Science ®Google Scholar
• Lehmann J. M., Jong L., Fanjul A., Cameron J. F., Lu X. P., Haefner P., Dawson M. I., Pfahl M. Retinoids Relective for Retinoid X Receptor Response Pathways. Science 1992; 258: 1944–1946
   PubMed Web of Science ®Google Scholar
• Zhang J., Hu X., Lazar M. A. A Novel Role for Helix 12 of Retinoid X Receptor in Regulating Repression. Mol. Cell. Biol. 1999; 19: 6448–6457
   PubMed Web of Science ®Google Scholar
• Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewski T., Chen J. Y., Staub A., Garnier J. -M., Mader S., Chambon P. Purification, Cloning and RXR Identity of the HeLa Cell Factor With Which RAR or TR Heterodimerize to Bind Target Sequences Efficiently. Cell 1992; 68: 377–395
   PubMed Web of Science ®Google Scholar
• Westin S., Kurokawa R., Nolte R. T., Wisely G. B., McInnerney E. M., Rose D. W., Milburn M. V, Rosenfeld M. G., Glass C. K. Interactions Controlling the Assembly of Nuclear-Receptor Heterodimers and Co-Activators. Nature 1998; 395: 199–202
   PubMed Web of Science ®Google Scholar
• Ordentlich P., Downes M., Xie W., Genin A., Spinner N. B., Evans R. M. Unique Forms of Human and Mouse Nuclear Receptor Corepressor SMRT. Proc. Natl. Acad. Sci. USA 1999; 96: 2639–2644
   PubMed Web of Science ®Google Scholar
• Cohen R. N., Putney A., Wondisford F. E., Hollenberg A. N. The Nuclear Corepressors Recognize Distinct Nuclear Receptor Complexes. Mol. Endocrinol. 2000; 14: 900–914
   PubMedGoogle Scholar
• Spencer T. E., Jenster G., Burcin M., Allis C. D., Zhou J., Mizzen C. A., McKenna N. J., Onate S. A., Tsai S. Y., Tsai M. -J., O'Malley B. W. SteroidReceptor Coactivator-1 is a Histone Acetyltransferase. Nature 1997; 389: 194–198
   PubMed Web of Science ®Google Scholar
• Ryu S., Stein J. P., Chung C. -T., Lee Y. -J., Kim J. H. Enhanced Apoptosis and Radiosensitization by Combined 13-cis Retinoic Acid and Interferon α2; Role of RARβ Gene. Int. J. Radiat. Oncol. Biol. Phys. 2001; 51: 785–790
   PubMed Web of Science ®Google Scholar
• Di Renzo J., Söderström M., Kurokawa R, Ogliastro M. -H., Ricote M., Ingrey S., Hörlein A., Rosenfeld M. G., Glass C. K. Peroxisome Proliferator Activated Receptor and Retinoic Acid Receptors Differentially Control the Interactions of Retinoid X Receptor Heterodimers With Ligands, Coactivators, and Corepressors. Mol. Cell. Biol. 1997; 17: 2166–2176
   PubMed Web of Science ®Google Scholar
• Smith C. L., Nawaz Z., O'Malley B. W. Coactivator and Corepressor Regulation of the Agonist/Antagonist Activity of the Mixed Antiestrogen, 4-Hydroxytamoxifen. Mol. Endocrinol. 1997; 11: 657–666
   PubMed Web of Science ®Google Scholar
• Jackson T. A., Richer J. K., Bain D. L., Takimoto G. S., Tung L., Horwitz K. B. The Partial Agonist Activity of the Antagonist-Occupied Steroid Receptorsis Controlled by a Novel Hinge Domain Binding Coactivator L7/SPA andthe Corepressors N-CoR and SMRT. Mol. Endocrinol. 1997; 11: 693–705
   PubMed Web of Science ®Google Scholar
• Hong S. -H, Privalsky M. L. Retinoid Isomers Differ in the Ability to Induce Release of SMRT Corepressor from Retinoic Acid Receptor-α. J. Biol. Chem. 1999; 274: 2885–2892
   PubMed Web of Science ®Google Scholar
• Lavinsky R. M., Jepsen K., Heinzel T., Torchia J., Mullen T. -M., Schiff R., Del-Rio A. L., Ricote M., Ngo S., Gemsch J., Hilsenbeck S. G., Osborne C. K., Glass C. K., Rosenfeld M. G., Rose D. W. Diverse Signalling Pathways Modulate Nuclear Receptor Recruitment of N-CoR and SMRT Complexes. Proc. Natl. Acad. Sci. USA 1998; 95: 2920–2925
   PubMed Web of Science ®Google Scholar
• Kurokawa R., Söderström M., Hörlein A., Halachmi S., Brown M., Rosenfeld M. G., Glass C. K. Polarity-Specific Activities of Retinoic Acid Receptors Determined by a Co-Repressor. Nature 1995; 377: 451–454
   PubMed Web of Science ®Google Scholar
• Eng F.C. S., Barsalou A., Akutsu N., Mercier I., Zechel C., Mader S., White J. H. Different Classes of Coactivators Recognize Distinct but Overlapping Binding Sites on the Estrogen Receptor Ligand Binding Domain. J. Biol. Chem. 1998; 273: 28371–28377
   PubMed Web of Science ®Google Scholar
• Egea P. F., Mitschler A., Rochel N., Ruff M., Chambon P., Moras D. Crystal Structure of the Human RXRα Ligand-Binding Domain Bound to Its Natural Ligand: 9-cis Retinoic Acid. EMBO J. 2000; 19: 2592–2601
   PubMed Web of Science ®Google Scholar
• Bourguet W., Germain P., Gronemeyer H. Nuclear Receptor Ligand-Binding Domains: Three Dimensional Structures, Molecular Interactions and Pharmacologiacl Implications. Trends Pharamcol. Sci. 2000; 21: 381–388
   PubMed Web of Science ®Google Scholar
• Pike A.C. W., Brzozowski A. M., Hubbard R. A., Bonn T., Thorsell A. -G., Engström O., Ljunggren J., Gustafsson J.-A., Carlquist M. Structure of the Ligand-Binding Domain of the Oestrogen Receptor Beta in the Presence of a Partial Agonist and a Full Antagonist. EMBO J. 1999; 18: 4608–4618
   PubMed Web of Science ®Google Scholar
• Oberfield J. L., Collins J. L., Holmes C. P., Goreham D. P., Cooper J. P., Cobb J. E., Lenhard J. M., Hull-Ryde E. A., Mohr C. P., Blanchard S. G., Parks D. J., Moore L. B., Lehmann J. M., Plunket K., Miller A. B., Milburn M. V., Kliewer S. A., Willson T. M. A Peroxisome Proliferator-Activated Receptor γ Ligand Inhibits Adipocyte Differentiation. Proc. Natl. Acad. Sci. USA 1999; 96: 6102–6106
   PubMed Web of Science ®Google Scholar